LAC Med Shares Up on Market Debut

Share Price Opens Above IPO Level on ACE Market

Kuala Lumpur, — LAC Med Bhd made a positive debut on Bursa Malaysia today, with its share price opening above the initial public offering (IPO) level as investors placed early bets on the healthcare solutions provider’s long-term growth trajectory.

The counter began trading on the ACE Market at a premium to its offer price, signalling stronger-than-expected demand from both retail and institutional participants. Market dealers attributed the initial gains to LAC Med’s sector positioning, improving healthcare expenditure trends, and rising interest in medical technology and diagnostics-related businesses.

Analysts noted that the group’s forward earnings visibility, supported by expanding service lines and capacity enhancement initiatives, contributed to the upbeat sentiment. LAC Med’s management previously highlighted its strategic focus on scaling its medical diagnostics capabilities, widening regional outreach, and strengthening partnerships within Malaysia’s healthcare ecosystem.

Trading volume remained active in the early session, with the counter emerging among the top gainers on the ACE Market. Market observers expect near-term volatility as investors reassess valuation levels following the early rally, but they believe the underlying fundamentals remain intact.

LAC Med’s successful debut also adds to the momentum of new listings on Bursa Malaysia, which continues to record improving pipeline activity across consumer, technology, and healthcare segments. Fund managers view the company’s performance as a constructive signal for the broader IPO market as investor appetite gradually recovers.